Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,522Revenue $M105Net Margin (%)-154.3Z-Score-2.1
Enterprise Value $M1,570EPS $-0.9Operating Margin %-152.0F-Score2
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-153.7Higher ROA y-yY
Price/Book18.910-y EBITDA Growth Rate %0Quick Ratio4.0Cash flow > EarningsY
Price/Sales33.95-y EBITDA Growth Rate %0Current Ratio4.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-35.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-132.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M187ROI % (ttm)-83.9Gross Margin Increase y-yN

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARIAGeorge Soros 2014-12-31 Sold Out -0.01%$5.02 - $7.46
($6.28)
$ 8.1330%Sold Out0
ARIAGeorge Soros 2014-09-30 Reduce-0.04%$5.01 - $6.5
($5.84)
$ 8.1339%Reduce -85%150,000
ARIAGeorge Soros 2014-06-30 Add0.02%$6.3 - $8.52
($6.89)
$ 8.1318%Add 100%1,000,000
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
($7.75)
$ 8.135%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
($5.16)
$ 8.1358%New holding, 1950000 sh.1,950,000
ARIADaniel Loeb 2013-06-30 Sold Out -0.94%$16.32 - $19.77
($17.73)
$ 8.13-54%Sold Out0
ARIADaniel Loeb 2012-12-31 Add0.4%$18.93 - $25.16
($22.12)
$ 8.13-63%Add 85.19%2,500,000
ARIAAndreas Halvorsen 2012-12-31 Sold Out -0.33%$18.93 - $25.16
($22.12)
$ 8.13-63%Sold Out0
ARIAAndreas Halvorsen 2012-09-30 Buy 0.33%$17.11 - $24.21
($19.85)
$ 8.13-59%New holding, 1934500 sh.1,934,500
ARIADaniel Loeb 2012-09-30 Reduce-0.39%$17.11 - $24.21
($19.85)
$ 8.13-59%Reduce -35.71%1,350,000
ARIADaniel Loeb 2012-06-30 Buy 1.1%$14.6 - $17.82
($16.35)
$ 8.13-50%New holding, 2100000 sh.2,100,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
($16.35)
$ 8.13-50%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
($13.74)
$ 8.13-41%New holding, 635000 sh.635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
($10.96)
$ 8.13-26%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
($10.54)
$ 8.13-23%New holding, 496847 sh.496,847
ARIAJean-Marie Eveillard 2008-06-30 Buy $2.39 - $3.57
($2.8)
$ 8.13190%New holding, 50000 sh.50,000
ARIAGeorge Soros 2008-06-30 Sold Out -0.01%$2.39 - $3.57
($2.8)
$ 8.13190%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARIA George Soros 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CLACKSON TIMOTHY PPresident, R&D, CSO 2015-02-20Sell49,035$82.13view
BERGER HARVEY J M DChairman & CEO 2015-02-12Buy25,000$6.8319.62view
Duvall Martin JEVP, CCO 2015-02-02Sell14,667$6.3329.07view
Cantor Maria ESVP, Corporate Affairs and HR 2015-02-02Sell16,134$6.3329.07view
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2015-02-02Sell14,667$6.3329.07view
CLACKSON TIMOTHY PPresident, R&D, CSO 2015-02-02Sell14,667$6.3329.07view
FITZGERALD EDWARD MExecutive VP, CFO 2015-02-02Sell14,667$6.3329.07view
BERSTEIN DAVID LSVP, Chief IP Counsel 2015-02-02Sell14,667$6.3329.07view
Haluska FrankSVP, Clinical R&D, CMO 2015-02-02Sell16,134$6.3329.07view
BERGER HARVEY J M DChairman & CEO 2015-01-23Buy25,000$6.1732.41view

Press Releases about ARIA :

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
comment on ARIA Mar 15 2013 
comment on ARIA Mar 15 2013 
comment on ARIA May 16 2012 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
creiter note on ARIA Jan 03 2010 

More From Other Websites
Why Ariad Pharmaceuticals Shares Are Undervalued Feb 24 2015
ARIAD to Present at the Cowen and Company 35th Annual Health Care Conference Feb 24 2015
ARIAD to Present at the Cowen and Company 35th Annual Health Care Conference Feb 24 2015
Ariad Pharmaceuticals, Inc., Quest Diagnostics Inc, Amgen, Inc.: Sarissa Capital’s Top Stock Picks... Feb 21 2015
Arista and Noodles are big market movers Feb 20 2015
Ariad's 2nd largest shareholder says it wants Berger replaced as CEO Feb 20 2015
Call buyers coming back to Ariad Feb 20 2015
Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
Sarissa Capital mounts proxy fight to oust Ariad CEO Feb 20 2015
ARIAD Confirms Receipt of Sarissa Capital Management’s Nomination of Director Candidates Feb 20 2015
ARIAD Confirms Receipt of Sarissa Capital Management’s Nomination of Director Candidates Feb 20 2015
Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger Feb 20 2015
Sarissa Capital seeks Ariad Pharma's CEO's ouster Feb 20 2015
Ariad's financials fail to impress as reports of CEO ouster continue Feb 19 2015
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape Feb 19 2015
Ariad reports 4Q loss Feb 19 2015
Ariad reports 4Q loss Feb 19 2015
ARIAD Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Feb 19 2015
ARIAD Reports 2014 Financial Results, Provides 2015 Financial Guidance and Outlines Strategic... Feb 19 2015
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 19 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK